Knowledge Papers

Med-ic® AND THE PHASE 2 GO/NO GO DECISION?

Patient compliance data can be highly effective in phase 2 post hoc analyses leading up to the go/no go decision regarding a move to phase 3. Once the phase 2 objectives of assessing safety, tolerability and effectiveness have been met, the question is whether or not to proceed to phase 3 with its considerable resource requirements.